Guidance

Human papillomavirus (HPV) vaccine: PGD template

Patient group direction (PGD) template to support the national human papillomavirus (HPV) vaccination programme.

• From: UK Health Security Agency
• Published: 12 June 2019
• Last updated: 6 July 2023 — See all updates

Applies to England

Documents

Human papillomavirus (HPV) vaccine: PGD template

Ref: UKHSA gateway number: GOV-14792

MS Word Document, 133 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This patient group direction (PGD) template supports the administration of HPV vaccine to individuals from 12 years of age or from school year 8 in accordance with the national immunisation programme.

HPV PGD version 6 is valid from 1 September 2023 to 1 September 2025.

Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement see Human Medicines Regulations 2012. Practitioners should follow local policy/procedures to access authorised PGD documents.

This PGD template should be used with reference to current national guidance, the Green Book, and Summary of Product Characteristics.

Published 12 June 2019
Last updated 6 July 2023 + show all updates

1. 6 July 2023

   Added version 6 – see page 3 for change history.

2. 8 March 2022

   Added version 5 - see page 2 for change history.

3. 5 August 2021

   Added updated PGD (V04.00).

4. 12 June 2019

   First published.